（原标题：港股异动 | 百奥赛图-B(02315)盈喜后涨近13% 预计全年营收增长约40% 纯利增长约400%） 智通财经APP获悉，百奥赛图-B(02315)盈喜后涨近13%，截至发稿，涨8.82%，报47.88港元，成交额 2771.5万港元。 公告称，受益于海外市场的持续拓展，叠加国内生物医药行业的复苏回暖，公司营业收入实现高速增 长；高壁垒的技术优势保障业务毛利维持高位，精益化管理举措进一步推动运营效率提升，公司盈利水 平得以快速提高。 消息面上，百奥赛图发布2025年度业绩预告，预计全年实现营收约13.69亿元-13.89亿元，较上年同期增 加3.89亿元至4.08亿元，同比增幅为39.61%到41.65%；预计实现归母净利润约为1.62亿元-1.82亿元，较 上年同期增加1.29亿元至1.49亿元，同比大幅增长384.26%至443.88%。 ...

Core Viewpoint - Spring Medical (01858) has shown a significant increase in stock price and is expected to report substantial profit growth for the fiscal year 2025, indicating strong operational performance and strategic initiatives [1] Financial Performance - The company forecasts a net profit attributable to shareholders of RMB 245 million to RMB 288 million for 2025, representing an increase of RMB 120 million to RMB 163 million compared to the previous year, which is a year-on-year growth of 96.01% to 130.41% [1] - The net profit attributable to shareholders after excluding non-recurring gains and losses is expected to be between RMB 230 million and RMB 270 million, reflecting an increase of RMB 135 million to RMB 175 million year-on-year, translating to a growth of 142.80% to 185.11% [1] Strategic Initiatives - The company attributes its expected profit growth to the gradual release of growth potential across its product lines following the inclusion in centralized procurement [1] - Spring Medical is committed to an international development strategy and is steadily advancing its international business layout, which supports sustained and healthy revenue growth [1] - The company is focusing on enhancing operational management, optimizing resource allocation, and improving overall efficiency and profitability, which are crucial for supporting its performance growth [1]

公告称，受益于海外市场的持续拓展，叠加国内生物医药行业的复苏回暖，公司营业收入实现高速增 长；高壁垒的技术优势保障业务毛利维持高位，精益化管理举措进一步推动运营效率提升，公司盈利水 平得以快速提高。 百奥赛图-B(02315)盈喜后涨近13%，截至发稿，涨8.82%，报47.88港元，成交额2771.5万港元。 消息面上，百奥赛图发布2025年度业绩预告，预计全年实现营收约13.69亿元-13.89亿元，较上年同期增 加3.89亿元至4.08亿元，同比增幅为39.61%到41.65%；预计实现归母净利润约为1.62亿元-1.82亿元，较 上年同期增加1.29亿元至1.49亿元，同比大幅增长384.26%至443.88%。 ...

公告称，报告期内公司归属于上市公司股东的净利润相比上年同期上升105%–204%，主要由于报告期 内公司非经常性损益大幅增加所致。报告期内，归属于上市公司股东的非经常性损益为人民币5亿元至 7.4亿元；上年同期归属于上市公司股东的非经常性损益为约人民币-4.5亿元，非经常性损益增加人民币 9.5亿元至11.9亿元。 经过不懈努力，公司的新签订单数量和金额均较上年同期实现较好增长。2025年，公司净新增订单(新 签订单剔除取消订单后)区间为人民币95亿元至人民币105亿元，2024年同期净新增订单为人民币84.20 亿元。 泰格医药（300347）(03347)盈喜后高开逾5%，截至发稿，涨5.39%，报53.75港元，成交额166.63万港 元。 消息面上，1月29日，泰格医药发布公告，该集团预期2025年实现营业收入66.6亿-76.8亿元，同比增长 1%至16%；归属于上市公司股东的净利润为8.3亿-12.3亿元，同比增长105%至204%；归属于上市公司 股东的扣除非经常性损益后的净利润约3.3亿-4.9亿元，同比下降61%至43%。 ...

Core Viewpoint - Ok Technology (001223.SZ) forecasts a significant increase in net profit for the fiscal year 2025, with expected growth rates of 113.40% to 138.51% compared to the previous year [1] Financial Performance - The net profit attributable to shareholders is projected to be between 927 million yuan and 1.036 billion yuan [1] - The net profit after deducting non-recurring gains and losses is expected to range from 41.7366 million yuan to 55.6850 million yuan, reflecting a year-on-year growth of 282.37% to 410.16% [1] - Basic earnings per share are estimated to be between 0.4982 yuan and 0.6476 yuan [1] Operational Highlights - The company has expanded production capacity for smart equipment orders and is systematically progressing with the delivery of previously announced orders [1] - Improvements have been made to the performance of household paper smart equipment [1] - Increased investment in research and development has been emphasized to drive innovation in products, supporting sustained growth in the company's equipment business [1] Revenue Growth - The total operating revenue and production capacity have both seen growth during the reporting period [1] - Revenue from materials has increased rapidly, with a notable growth in PI materials, as the company seeks to expand into other application fields [1]

格隆汇1月30日丨德尔股份(300473.SZ)发布2025年度业绩预告，报告期内，归属于上市公司股东的净利 润1.30亿元～1.70亿元，同比增长132.63%～204.21%；扣除非经常性损益后的净利润9,500万元～1.28亿 元，同比增长265.15%～391.99%。报告期内，公司运营效率随业务发展持续改善，内部管理的优化举 措亦见成效，收入提升的同时管理费用和财务费用得到了管控，共同带动了盈利水平的稳步提升。 ...

Core Viewpoint - The company expects to achieve positive net profit in 2025, marking a turnaround from previous losses, driven by strategic operational improvements and brand positioning efforts [2][3]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an anticipated positive net profit indicating a turnaround situation [1][2]. - The financial data related to the performance forecast is based on preliminary calculations by the company's finance department and has not yet been audited by registered accountants [2]. Group 2: Reasons for Performance Change - The year 2025 is seen as the first year of effective implementation of the company's strategic measures, leading to overall performance recovery and positive net profit growth [3]. - The company has accelerated channel transformation by adding new stores that align with its brand positioning, including the successful opening of its first flagship store in Shanghai, enhancing brand visibility and market presence [3]. - A clear brand positioning strategy has been employed to restructure product lines, attracting repeat purchases from existing customers and increasing overall brand value [3]. - Marketing strategies and membership system optimizations have improved new customer conversion rates and increased member engagement, contributing to stable performance growth [3]. - The company has implemented lean management practices, enhancing budget management and cost control, which has further improved operational efficiency [4]. - Improved management of accounts receivable and inventory has led to a reduction in expected credit losses and asset impairment losses compared to the previous year, positively impacting profits [4]. Group 3: Future Outlook - The company plans to maintain strategic focus, deepen core business operations, and actively explore market opportunities to achieve sustained and healthy performance growth [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301141 证券简称：中科磁业 公告编号：2026-003 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、 本期业绩预计情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 特此公告。 □扭亏为盈 R同向上升 □同向下降 二、 与会计师事务所沟通情况 本次业绩预告的相关数据是公司财务部门初步测算结果，未经审计机构审计。公司已就业绩预告有关事 项与年报审计会计师事务所进行预沟通，公司与会计师事务所在本次业绩预告方面不存在重大分歧。 三、 业绩变动原因说明 报告期内，一方面随着募投项目部分达产，产能逐渐释放，产销量提升，带动业绩规模增长；另一方面 公司坚持以客户需求为导向，持续推动产品与技术的更新迭代，公司产品从单一电子元器件拓展至磁组 件的集成化升级，目前公司磁组件产品已顺利通过部分客户的验证，进入小批量供货阶段；与此同时， 公司不断深化与头部大客户的战略合作，持续提升在大客户端的市场份额，并加速拓展增量新客户，提 高公司产品的市场占有 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 （一）业绩预告期间：2025年1月1日至2025年12月31日 （二）业绩预告情况：预计净利润为正值且属于同向上升50%以上情形 二、与会计师事务所沟通情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002357 证券简称：富临运业 公告编号：2026-003 （一）公司合营企业因土地收储确认相关非经常性损益。 （二）受联营企业盈利增长等因素影响，公司按照权益法核算的投资收益增加。 （三）公司持续推动精益管理，优化费用结构与成本管控，报告期内降本工作取得较好成果。 四、其他相关说明 本次业绩预告是公司财务部门初步测算的结果，未经会计师事务所审计，具体财务数据以公司披露的 2025年年度报告为准。敬请广大投资者谨慎决策，注意投资风险。 特此公告。 本次业绩预告相关财务数据未经会计师事务所审计。公司已就业绩预告有关事项与会计师事务所进行了 预沟通，双方在本报告期业绩预告方面不存在重大分歧。 三、业绩变动原因说明 四川富临运业集团股份有限公司 董事会 二〇二六年一月二十九日 ...

证券代码：688025 证券简称：杰普特 公告编号：2026-002 深圳市杰普特光电股份有限公司2025年年度业绩预增公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日 （二）业绩预告情况 2、预计2025年年度实现归属母公司所有者的净利润26,230.00万元至30,900.00万元，较上年同期相比， 将增加12,961.52万元至17,631.52万元，同比增长约97.69%至132.88%； 3、预计2025年年度实现归属母公司所有者的扣除非经常性损益后的净利润25,300.00万元至30,000.00万 元，较上年同期相比，将增加14,743.48万元至19,443.48万元，同比增长约139.66%至184.18%。 （三）本次业绩预告数据未经注册会计师审计。 三、本期业绩变化的主要原因 报告期内公司受益于全球范围内激光器需求提升，在新能源动力电池精密加工及消费级激光器领域实现 销售收入的较快增长，同时公司光通信业务快速切入 ...